LumaCyte

LumaCyte’s mission is to provide developers and manufacturer scientists with transformational analytical tools that accelerate medical and biopharmaceutical discoveries through novel cellular process analytics and characterization. Our vision is to empower scientists to ask questions and seek answers without the bias of antibodies or labels. At LumaCyte, we are passionate about transforming the status quo. Applications of LumaCyte’s label-free platform technology include viral infectivity for vaccine development and manufacturing, cell health, activation, transfection and transduction analytics for cell and gene therapy development and production monitoring, CAR T-cell immunotherapy, iPSC differentiation, adventitious agent testing (AAT), infectious disease, and pre-clinical drug discovery, in addition to multiple applications across advanced therapy biomanufacturing for real-time quality control. LumaCyte is an advanced research and bioanalytics instrumentation company that produces label-free, single cell analysis instrumentation where the use of antibody or genetic labeling is not required for cellular analysis. LumaCyte Laser Force Cytology™ (LFC) is transforming the status quo through its novel label-free, single cell advanced analytics. ReportR™, LumaCyte’s fully automated cloud-based analysis and report generation software platform, takes the Radiance® user experience to the next level, delivering a more robust and efficient approach to traditional data analysis efforts. As a result, LumaCyte’s end-to-end ReportR™ offering streamlines laboratory workflows and accelerates time to results (TTR).